Nephrotic range of proteinuria in long standing rheumatoid arthritis: a diagnostic challenge
DOI:
https://doi.org/10.18203/2349-3933.ijam20230064Keywords:
Tuberculosis, Rheumatoid arthritis, ProteinuriaAbstract
A 54-year-old male, a sero positive rheumatoid arthritis on treatment for 5 years, switched over to native drugs for 6 months. He was admitted with features suggestive of nephrotic range of proteinuria (Urine PCR- 8.32). A differential diagnosis of drug induced rheumatoid arthritis-amyloidosis was entertained. He underwent renal biopsy showed Membranous nephropathy (MN) (anti-phospholipase A2 receptor antibody PLA2R-positive). He was treated with high dose steroids, angiotensin receptor blockers and leflunomide as DMARD for rheumatoid arthritis. Nephrologist did not want to start mycophenolate mofetil/ rituximab since it was 1o MN. The proteinuria even after 1 month of steroids did not show any reduction; though anti-phospholipase A2 receptor antibody positive is a negative predictor for other secondary causes, considering his age and being a chronic smoker, we did a PET scan to rule out an internal malignancy. It revealed a metabolically active lesion in right upper lobe of the lung; Bronchoalveolar lavage (BAL) was done in that CBNAAT showed Mycobacterium tuberculosis positive. ATT was started and steroids tapered; a month into ATT, then Urine PCR reduced to 2 and at 3rd month of ATT, PCR was <1 and disease is under remission.
References
Carmona L. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol. 2003;30:1436-9.
Kanaji N, Kushida Y, Bandoh S, Ishii T, Haba R, Tadokoro A et al. Membranous glomerulonephritis associated with Mycobacterium shimoidei pulmonary infection. Am J Case Rep. 2013;14:543-7.
Moroni G. Secondary Membranous Nephropathy. A Narrative Review Front. Med. 2020.
Keane J, Gershon S, Wise RP. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098-104.
Lida A, Wada Y, Hayashi J, Tachibana S, Inaba T, Iyoda M, Honda K, Shibata T. Membranous nephropathy caused by rheumatoid arthritis. CEN Case Rep. 2019;8(4):233-8.
Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clin Nephrol. 2003;59:137-42.
Muthukumar P, Dhanapriya J, Gopalakrishnan N, Dineshkumar T, Sakthirajan R, Balasubramaniyan T. Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis. Saudi J Kidney Dis Transpl. 2017;28:44-50.
Pixley JS, Wolf BJ, O'Neill W. Membranous nephropathy associated with rheumatoid arthritis may respond to rituximab. Scand J Rheumatol. 2008;37:313-9.
Shribman JH, Eastwood JB, Uff J. Immune complex nephritis complicating miliary tuberculosis. Br Med J. 1983;287:1593-4.
Mercadal L, Martinez F, Barrou B, Delcourt A, Deray G, Jacobs C et al. Retroperitoneal fibrosis and membranous nephropathy. Clin Nephrol. 2000;53:71-4.
Chan TM, Li FK, Hao WK, Chan KW, Lui SL et al. Treatment of membranous lupus nephritis with nephritic syndrome by sequential immunosuppression. Lupus. 1999;8:545-31.
Han BG, Choi SO, Lee SJ, Kim YH, Hong WP, Lee JH. Choroidal tuberculoma with membranous glomerulonephritis. Yonsei Med J. 2001;42:446-50.
Bourke BE. Proteinuria in rheumatoid arthritis: drug-induced or amyloid? Ann Rheum Dis. 1981;40:2404.
Boers M. Renal disorders in rheumatoid arthritis. Semin Arthritis Rheum. 1990;20:57-68.
Kapoor T, Bathon J. Renal Manifestations of Rheumatoid Arthritis. Rheum Dis Clin North Am. 2018;44(4):571-84.
